ICAAC 45th

Title Content type
In vivo Efficacy of the triazole BAL8557 (BAL) Compared to Voriconazole (VOR), Itraconazole (ITC) and Caspofungin (CAS) By a New qPCR and Quantitative Culture in a Neutropenic Murine Model of Aspergillus flavus (click for details)
Dose Response Curves and Dose Fractionation Studies with BAL8557 in a Murine Model of Disseminated Candidiasis (click for details)
Antifungal Activity of BAL4815, a Novel Azole Against Dermatophytes and Emerging Non-Dermatophyte Fungi Including Zygomycetes (click for details)
In vitro activity of the new azole BAL4815 against clinical dermatophyte isolates (click for details)
In Vitro Activity of the New Azole BAL4815 against Clinical Candida Isolates Comprising Resistant C. albicans and Less Susceptible Candida spp (click for details)
Efficacy, Safety, and Tolerability of three Different Dosing Regimens of BAL8557 Vs. Fluconazole in a Double-Blind, Randomized, Multicenter Trial for the Treatment of Esophageal Candidiasis in Immunocompromised Adults (click for details)
Safety of Caspofungin (CAS) During Concomitant Immunosuppressant (IS) Therapy (click for details)
In Vivo Efficacy of Aerosolized Nano-Structured Itraconazole Formulations for the Prevention of Invasive Pulmonary Aspergillosis (IPA) (click for details)
The Pharmacokinetics (PK) of Oral Posaconazole (POS) in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with Graft-Versus-Host Disease (GVHD) (click for details)
Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program (click for details)


Subscribe to ICAAC 45th